Risks and benefits of bariatric surgery: Current evidence

Stacy A. Brethauer, MD
Section of Advanced Laparoscopic and Bariatric Surgery, Department of General Surgery, Cleveland Clinic

Bipan Chand, MD
Director, Section of Surgical Endoscopy, Department of General Surgery, Cleveland Clinic

Philip R. Schauer, MD
Director, Bariatric and Metabolic Institute, Cleveland Clinic; professor of surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Address: Philip R. Schauer, MD, Director, Bariatric and Metabolic Institute, M61, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail schauep@ccf.org

Dr. Brethauer has disclosed receiving research support from the Ethicon Endo-Surgery, Bard Davol, and Tyco US Surgical corporations.

Dr. Chand has disclosed serving as a consultant for the Ethicon Endo-Surgery, Sanofi-Aventis, and Gore corporations.

Dr. Schauer has disclosed receiving research support from, serving as a consultant for, or receiving speaking honoraria from the Ethicon Endo-Surgery, Bard Davol, Gore, Baxter, Stryker, Invacare, Wyeth, and Dowden corporations.

Stacy A. Brethauer, MD
Section of Advanced Laparoscopic and Bariatric Surgery, Department of General Surgery, Cleveland Clinic

Bipan Chand, MD
Director, Section of Surgical Endoscopy, Department of General Surgery, Cleveland Clinic

Philip R. Schauer, MD
Director, Bariatric and Metabolic Institute, Cleveland Clinic; professor of surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Address: Philip R. Schauer, MD, Director, Bariatric and Metabolic Institute, M61, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail schauep@ccf.org

Dr. Brethauer has disclosed receiving research support from the Ethicon Endo-Surgery, Bard Davol, and Tyco US Surgical corporations.

Dr. Chand has disclosed serving as a consultant for the Ethicon Endo-Surgery, Sanofi-Aventis, and Gore corporations.

Dr. Schauer has disclosed receiving research support from, serving as a consultant for, or receiving speaking honoraria from the Ethicon Endo-Surgery, Bard Davol, Gore, Baxter, Stryker, Invacare, Wyeth, and Dowden corporations.

Stacy A. Brethauer, MD
Section of Advanced Laparoscopic and Bariatric Surgery, Department of General Surgery, Cleveland Clinic

Bipan Chand, MD
Director, Section of Surgical Endoscopy, Department of General Surgery, Cleveland Clinic

Philip R. Schauer, MD
Director, Bariatric and Metabolic Institute, Cleveland Clinic; professor of surgery, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Address: Philip R. Schauer, MD, Director, Bariatric and Metabolic Institute, M61, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail schauep@ccf.org

Dr. Brethauer has disclosed receiving research support from the Ethicon Endo-Surgery, Bard Davol, and Tyco US Surgical corporations.

Dr. Chand has disclosed serving as a consultant for the Ethicon Endo-Surgery, Sanofi-Aventis, and Gore corporations.

Dr. Schauer has disclosed receiving research support from, serving as a consultant for, or receiving speaking honoraria from the Ethicon Endo-Surgery, Bard Davol, Gore, Baxter, Stryker, Invacare, Wyeth, and Dowden corporations.